(Q48211755)

English

Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

Mohammad Ali Shokrgozar

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

Marie-France Cesbron-Delauw

7

object named as

Marie-France Cesbron-Delauw

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

Corinne Mercier

8

object named as

Corinne Mercier

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

4

object named as

Karine Musset

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

1

object named as

Majid Golkar

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

author name string

Mehdi Assmar

5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

Reza Sadaie

6

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

language of work or name

0 references

publication date

9 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

25

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

21

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

4301-4311

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

Central nervous system infections in individuals with HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Zoonotic protozoa: from land to sea.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Induction and regulation of IL-12-dependent host resistance to Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Interferon-gamma: the major mediator of resistance against Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

A decade of discoveries in veterinary protozoology changes our concept of "subclinical" toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

A commercial vaccine for ovine toxoplasmosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Vaccination withToxoplasma gondiiSAG-1 Protein Is Protective against Congenital Toxoplasmosis in BALB/c Mice but Not in CBA/J Mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondii.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Dense granules: are they key organelles to help understand the parasitophorous vacuole of all apicomplexa parasites?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Characterisation of a secretory antigen from Toxoplasma gondii and its role in circulating antigen production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Detection and characterization of circulating antigens in acute experimental infections of mice with four different strains of Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

The dense granule protein GRA2, a new marker for the serodiagnosis of acute Toxoplasma infection: comparison of sera collected in both France and Iran from pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Protective immunity in the rat model of congenital toxoplasmosis and the potential of excreted-secreted antigens as vaccine components.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Limited value of assays using detection of immunoglobulin G antibodies to the two recombinant dense granule antigens, GRA1 and GRA6 Nt of Toxoplasma gondii, for distinguishing between acute and chronic infections in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Toxoplasma gondii: an evaluation of diagnostic value of recombinant antigens in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Taking toll: lipid A mimetics as adjuvants and immunomodulators

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Escherichia coli beta-galactosidase as an in vitro and in vivo reporter enzyme and stable transfection marker in the intracellular protozoan parasite Toxoplasma gondii.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Induction of a protective antibody-dependent response against toxoplasmosis by in vitro excreted/secreted antigens from tachyzoites of Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Molecular characterization of a dense granule antigen (Gra 2) associated with the network of the parasitophorous vacuole in Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Characterization of a dense granule antigen of Toxoplasma gondii (GRA6) associated to the network of the parasitophorous vacuole

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Cloning, overexpression, and purification of the recombinant His-tagged SSB protein of Escherichia coli and use in polymerase chain reaction amplification

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Toxoplasma gondii: characterization and localization of antigens secreted from tachyzoites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Differential membrane targeting of the secretory proteins GRA4 and GRA6 within the parasitophorous vacuole formed by Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Major surface protein of Toxoplasma gondii (p30) contains an immunodominant region with repetitive epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Genomic and corrected cDNA sequence of the P28 gene from Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Enzyme-linked immunosorbent assays using the recombinant dense granule antigens GRA6 and GRA1 of Toxoplasma gondii for detection of immunoglobulin G antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Response to influenza infection in mice with a targeted disruption in the interferon gamma gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

IFN-gamma-independent IgG2a production in mice infected with viruses and parasites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Effects of specific monoclonal antibodies to dense granular proteins on the invasion of Toxoplasma gondii in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

Detection of nucleoside triphosphate hydrolase as a circulating antigen in sera of mice infected with Toxoplasma gondii.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.057

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.02.057

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17418457

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48211755&oldid=2190662696"